Arbutus Biopharma (ABUS) Prepaid Assets (2010 - 2026)

Arbutus Biopharma has disclosed Prepaid Assets across 17 years of filings, most recently posting $1.7 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $1.7 million, down 40.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 40.66% YoY), and the FY2025 annual result was $1.5 million, down 32.66% from the prior year.
• Prepaid Assets came in at $1.7 million for Q1 2026 at Arbutus Biopharma, up from $1.5 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $5.9 million in Q1 2022 to a low of $1.5 million in Q4 2025.
• The 5-year median for Prepaid Assets is $3.7 million (2023), against an average of $3.7 million.
• Across the five-year window, Prepaid Assets jumped 48.38% in 2022 and sank 46.23% in 2024, its largest moves.
• Arbutus Biopharma's Prepaid Assets stood at $2.9 million in 2022, then jumped by 47.81% to $4.2 million in 2023, then plunged by 46.23% to $2.3 million in 2024, then slumped by 32.66% to $1.5 million in 2025, then grew by 12.61% to $1.7 million in 2026.
• The last three Prepaid Assets figures came in at $1.7 million (Q1 2026), $1.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.